It's incomprehensible that the share price goes upon these appalling results. Cost of manufacture is higher than sales receipts from clients to give a cash “loss” of $6m. Take out the R&D tax that's over $10m.
Cann needs cash to repay loans, hard to see how they going to do it, growing more cannabis equals higher losses. Surely the new management are seeing it? They are currently locked to a death spiral. LGP has a similar problem.
- Forums
- ASX - By Stock
- Ann: Quarterly activities report and Appendix 4C - December 2023
It's incomprehensible that the share price goes upon these...
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAN (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.12M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAN (ASX) Chart |
Day chart unavailable